Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: J Mass Spectrom. 2014 Aug;49(8):665–673. doi: 10.1002/jms.3411

Table 1.

MS/MS fragmentation of CA derivatized amino acids, neurotransmitters and isobaric analogs

Compounda [M + H]+ MS/MS Fragments, m/zb MS3 Fragment, m/z
Dopamine 314 137, 178, 190, 259
4-hydroxy-3-methoxybenzylamine 137, 178
Norepinephrine 330 161, 188, 312 152c
5-hydroxydopamine 153, 178, 206, 275
6-hydroxydopamine 151, 153, 178, 275
Epinephrine 344 137, 166, 190, 208
dl-normetanephrine 175, 202, 326
GABA 264 161, 178, 191, 209 191d
dl-2-aminobutyric acid 161, 218
2-aminoisobutyric acid 161,218
dl-3-aminoisobutyric acid 161, 190, 209, 246 153d
N-ethylglycine 151, 161, 181
N-methyl-L-alanine 128, 137, 161
Tryptophan 365 178, 236, 272, 348
Tyrosine 342 161, 165, 342182, 296
Glutamic acid 308 148, 161, 262, 290
Serotonin 337 160, 178, 228, 282, 294, 308, 320
Melatonin 393 233, 243, 269, 334
a

Derivatized (with 4-hydroxy-3-methoxycinnamaldehyde) amino acid or neurotransmitter is underlined with its isobaric analog listed below

b

Target amino acid or neurotransmitter fragment mass highlighted in bold if used for ion image reconstruction

c

Transition used for norepinephrine-CA (m/z 330→312→152) ion image reconstruction

d

Fragment mass used for confirmation of identity (m/z 264→209→)